Chemoinformaics analysis of 2-Methyl-1,3-pentadiene
| Molecular Weight | 82.146 | nRot | 1 |
| Heavy Atom Molecular Weight | 72.066 | nRig | 2 |
| Exact Molecular Weight | 82.0782 | nRing | 0 |
| Solubility: LogS | -1.655 | nHRing | 0 |
| Solubility: LogP | 1.806 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 16.6879 |
| nHD | 0 | BPOL | 10.0321 |
| QED | 0.425 |
| Synth | 3.288 |
| Natural Product Likeliness | 2.253 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.178 |
| MDCK | 0.0000298 |
| BBB | 0.992 |
| PPB | 0.586028 |
| VDSS | 1.231 |
| FU | 0.613846 |
| CYP1A2-inh | 0.836 |
| CYP1A2-sub | 0.932 |
| CYP2c19-inh | 0.121 |
| CYP2c19-sub | 0.884 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.933 |
| CYP2d6-inh | 0.065 |
| CYP2d6-sub | 0.891 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.266 |
| CL | 7.775 |
| T12 | 0.773 |
| hERG | 0.009 |
| Ames | 0.059 |
| ROA | 0.037 |
| SkinSen | 0.851 |
| Carcinogencity | 0.657 |
| EI | 0.996 |
| Respiratory | 0.768 |
| NR-Aromatase | 0.021 |
| Antiviral | No |
| Prediction | 0.948376 |